New use for old drugs: Epirubicin in colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New use for old drugs: Epirubicin in colorectal cancer

Published:2021-03-30 Issue:7 Volume:60 Page:954-956
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Tarpgaard Line S.¹^ORCID,Qvortrup Camilla²,Nielsen Signe L.³,Stenvang Jan³,Detlefsen Sönke⁴⁵^ORCID,Brünner Nils³,Pfeiffer Per¹⁵

Affiliation:

1. Department of Oncology, Odense University Hospital, Odense, Denmark

2. Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

3. Faculty of Health and Medical Sciences, Institute of Drug Design and Pharmacology, University of Copenhagen, Frederiksberg, Denmark

4. Department of Pathology, Odense University Hospital, Odense, Denmark

5. Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Funder

Kraeftens Bekaempelse

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1904519

Reference16 articles.

1. A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification

2. A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/− targeted therapy

3. HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

4. The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures

5. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIM24/ZFX affects the stemness and resistance to 5-FU of colorectal cancer cells;Journal of Chemotherapy;2024-09-02

2. Composition, preparation methods, and applications of nanoniosomes as codelivery systems: a review of emerging therapies with emphasis on cancer;Nanoscale;2024

3. Magnetic Solid-Phase Microextraction Protocol Based on Didodecyldimethylammonium Bromide-Functionalized Nanoparticles for the Quantification of Epirubicin in Biological Matrices;Pharmaceutics;2023-04-12

4. Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer;Biomedicines;2023-01-14

5. pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer;ACS Applied Bio Materials;2022-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3